J Dev Behav Pediatr. 1992 Aug;13(4):284-7.

A combined behavioral/pharmacological treatment of sleep-wake schedule disorder in Angelman syndrome.

Summers JA, Lynch PS, Harris JC, Burke JC, Allison DB, Sandler L.

Source

Department of Behavioral Psychology, Kennedy Krieger Institute, Baltimore, MD 21205.

Abstract

Angelman syndrome (AS) is a genetic disorder associated with a deletion on chromosome 15. Behavior problems among children with AS include sleep difficulties. Data are presented on the successful treatment of a sleep-wake schedule disorder (SWSD) in a 9-year-old boy with AS. The treatment program included behavioral and pharmacological components. During baseline, the child slept a mean of 1.9 hours per night and 1.3 hours during the day; night sleep was increased to a mean of 8.3 hours and day sleep was reduced to a mean of .08 hours after introduction of the full-treatment program. Medication was discontinued subsequently, and the child slept a mean of 7.8 hours during the night and .07 hours during the day. At 45-day follow-up, night sleep was maintained at 7.1 hours and day sleep remained stable at .29 hours. This is the first known report of an effective treatment of a SWSD in a child with AS.

PMID:: 1506469; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Ovid Technologies, Inc.

Other Literature Sources

COS Scholar Universe

Medical

Molecular Biology Databases

DIPHENHYDRAMINE - HSDB

Supplemental Content

Save items

Related citations in PubMed

[Inversion of the circadian melatonin rhythm in Smith-Magenis syndrome]. [Rev Neurol (Paris). 2003]
[Inversion of the circadian melatonin rhythm in Smith-Magenis syndrome].
De Leersnyder H, de Blois MC, Bresson JL, Sidi D, Claustrat B, Munnich A. Rev Neurol (Paris). 2003 Nov; 159(11 Suppl):6S21-6.
Review Clinical features in 27 patients with Angelman syndrome resulting from DNA deletion. [J Med Genet. 1996]
Review Clinical features in 27 patients with Angelman syndrome resulting from DNA deletion.
Smith A, Wiles C, Haan E, McGill J, Wallace G, Dixon J, Selby R, Colley A, Marks R, Trent RJ. J Med Genet. 1996 Feb; 33(2):107-12.
Long-term follow-up study of 10 adolescent patients with sleep-wake schedule disorders. [Jpn J Psychiatry Neurol. 1994]
Long-term follow-up study of 10 adolescent patients with sleep-wake schedule disorders.
Ando K, Hayakawa T, Ohta T, Kayukawa Y, Ito A, Iwata T, Okada T. Jpn J Psychiatry Neurol. 1994 Mar; 48(1):37-41.
A faded bedtime with response cost protocol for treatment of multiple sleep problems in children. [J Appl Behav Anal. 1991]
A faded bedtime with response cost protocol for treatment of multiple sleep problems in children.
Piazza CC, Fisher W. J Appl Behav Anal. 1991 Spring; 24(1):129-40.
Review Circadian rhythm sleep disorders: pathophysiology and treatment. [J Clin Neurophysiol. 1996]
Review Circadian rhythm sleep disorders: pathophysiology and treatment.
Richardson GS, Malin HV. J Clin Neurophysiol. 1996 Jan; 13(1):17-31.

See reviews... See all...

Cited by 1 PubMed Central article

Review Genetics of narcolepsy and other sleep disorders. [Am J Hum Genet. 1997]
Review Genetics of narcolepsy and other sleep disorders.
Mignot E. Am J Hum Genet. 1997 Jun; 60(6):1289-302.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A combined behavioral/pharmacological treatment of sleep-wake schedule disorder ...
A combined behavioral/pharmacological treatment of sleep-wake schedule disorder in Angelman syndrome.
J Dev Behav Pediatr. 1992 Aug ;13(4):284-7.

PubMed
Cloning of the canine ABCA4 gene and evaluation in canine cone-rod dystrophies a...
Cloning of the canine ABCA4 gene and evaluation in canine cone-rod dystrophies and progressive retinal atrophies.
Mol Vis. 2004 Mar 29 ;10:223-32.

PubMed
Prehension synergies.
Prehension synergies.
Exerc Sport Sci Rev. 2004 Apr ;32(2):75-80.

PubMed
Myristoylated Naked2 escorts transforming growth factor alpha to the basolateral...
Myristoylated Naked2 escorts transforming growth factor alpha to the basolateral plasma membrane of polarized epithelial cells.
Proc Natl Acad Sci U S A. 2004 Apr 13 ;101(15):5571-6. Epub 2004 Apr 2 .

PubMed
Suspected local recurrence after radical prostatectomy: endorectal coil MR imagi...
Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging.
Radiology. 2004 May ;231(2):379-85. Epub 2004 Apr 2 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

A combined behavioral/pharmacological treatment of sleep-wake schedule disorder in Angelman syndrome.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information